Epithalon 10mg – High-Purity Research Peptide
Epithalon (also known as Epitalon) is a synthetic tetrapeptide commonly utilised in laboratory research involving peptide structure, cellular signalling pathways, and pineal gland–related studies.
Supplied in lyophilised (freeze-dried) form to support stability and handling, this compound is verified at >99.1% purity (HPLC-tested) and provided with full Certificates of Analysis (COAs) for batch-specific verification and traceability.
What is Epithalon?
Epithalon is a peptide composed of the amino acid sequence Ala-Glu-Asp-Gly, originally identified through research involving the pineal gland. In controlled research environments, it is used as a model compound in studies examining peptide interactions, cellular processes, and experimental biological systems.
Scientific Identifiers
-
Product Name: Epithalon 10mg
-
Catalogue Number: BWP-EPI-10
-
CAS Number: 307297-39-8
-
Molecular Formula: C₁₄H₂₂N₄O₉
-
Molecular Weight: 390.35 g/mol
-
Sequence: Ala–Glu–Asp–Gly
-
Form: Lyophilised Solid
-
Purity: >99.1% (HPLC Verified)
-
Storage: Store at −20°C, protected from light
-
Unit Size: 10mg
Usage and Reconstitution
Epithalon is supplied as a lyophilised solid to ensure long-term stability. For laboratory use, it may be reconstituted with bacteriostatic water or other suitable solvents according to established research protocols. For additional guidance, please refer to our peptide reconstitution page.
Why Order Epithalon from Bluewell Peptides?
-
99.1% purity, HPLC-verified
-
COA provided with every batch
-
Secure ordering and fast UK delivery
-
Transparent, research-focused supplier
-
Excellent customer support and trusted reviews
Legal and Safety Information
Bluewell Peptides products are supplied strictly for laboratory research and educational purposes only. They are not approved for human or veterinary use. These compounds are not intended to diagnose, treat, cure, or prevent any disease. Use must comply with all applicable laws and regulations.






Reviews
There are no reviews yet.